Literature DB >> 7520463

Monoclonal antibody COL-1 reacts with restricted epitopes on carcinoembryonic antigen: an immunohistochemical study.

Z R Shi1, D Tacha, S H Itzkowitz.   

Abstract

We used a monoclonal antibody, MAb COL-1, which recognized a restricted epitope on the carcinoembryonic antigen (CEA) molecule, to stain a wide variety of human normal and cancerous tissues. None of the 35 different types of normal tissue stained with COL-1. Of 59 types of benign and malignant tissues, COL-1 reacted with neoplasms of epithelial origin, especially the gastrointestinal tract, breast, lung, and bladder. In benign adenomatous colon polyps, villous adenomas were more frequently stained than tubular adenomas. Normal colon tissue from individuals without colon disease was unreactive, but very weak reactivity was noted in normal-appearing mucosa several centimeters remote from colon cancers. In contrast, another anti-CEA antibody with a less restricted epitope reacted frequently with both normal and remote colon mucosa. These results indicate that MAb COL-1 recognizes a restricted CEA epitope expressed only on pre-malignant or malignant cells and therefore may be a useful reagent for immunopathology.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7520463     DOI: 10.1177/42.9.7520463

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  3 in total

1.  Micromachine-enabled capture and isolation of cancer cells in complex media.

Authors:  Shankar Balasubramanian; Daniel Kagan; Che-Ming Jack Hu; Susana Campuzano; M Jesus Lobo-Castañon; Nicole Lim; Dae Y Kang; Maria Zimmerman; Liangfang Zhang; Joseph Wang
Journal:  Angew Chem Int Ed Engl       Date:  2011-04-07       Impact factor: 15.336

Review 2.  A comprehensive overview of radioguided surgery using gamma detection probe technology.

Authors:  Stephen P Povoski; Ryan L Neff; Cathy M Mojzisik; David M O'Malley; George H Hinkle; Nathan C Hall; Douglas A Murrey; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2009-01-27       Impact factor: 2.754

3.  The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity.

Authors:  Fiona C Thistlethwaite; David E Gilham; Ryan D Guest; Dominic G Rothwell; Manon Pillai; Deborah J Burt; Andrea J Byatte; Natalia Kirillova; Juan W Valle; Surinder K Sharma; Kerry A Chester; Nigel B Westwood; Sarah E R Halford; Stephen Nabarro; Susan Wan; Eric Austin; Robert E Hawkins
Journal:  Cancer Immunol Immunother       Date:  2017-06-28       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.